Avvio Medical Inc. (formerly Applaud Medical, Inc.) today announced that results from its AEROLITH randomized clinical trial ...

Plenary presentation of data showing primary efficacy endpoint met – significant analgesia across all doses Significant improvement in all signs and symptoms of osteoarthritis for all doses ...

Two abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic (CAB) technology Differentiated preclinical activity for CAB anti-Nectin4-antibody ...

Poster presentations may not seem as prestigious as oral presentations, but they are a great opportunity to interact with other scientists in your field in a reasonably structured way. Just like ...

Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the 2025 American Society of Clinical Oncology Annual Meeting, scheduled for May 30 to June ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference in Chicago, highlighting the safety and efficacy of its product, ADG126, an anti-CTLA-4 masking antibody, in combination ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

The posters will be either a physical print or digital presentation as an individual or group presentation. All submissions will be reviewed by a panel of faculty and administrative judges. Posters ...

We hypothesized that ceramide modulates an immune mechansism that depletes tryptophan, causing Chlamydia to uptake and destroy it.

Poster presentation at the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL. November 28-December 3, 2010. Zelenak TG, Tan KC, O'Malley JP, ...